Cellyan Biotechnology Co

Cellyan Biotechnology Co EBITDA per Share

The EBITDA per Share of Cellyan Biotechnology Co (HKPD) as of Nov 1, 2026 is -0.03 USD. In the previous year, EBITDA per Share was 0.01 USD — a change of -327.24% (lower).

EBITDA per Share

-0.03USD

YoY

-327.24%

Last updated:

EBITDA per Share of Cellyan Biotechnology Co is 2026 -0.03 USD. EBITDA per Share of Cellyan Biotechnology Co was 2025 0.01 USD. It decreases by -327.24% lower compared to the previous year.

The Cellyan Biotechnology Co EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2023
0.15 USD
Jan 1, 2024
0.15 USD
Jan 1, 2025
0.01 USD
Jan 1, 2026
-0.03 USD
The Cellyan Biotechnology Co EBITDA per Share history
YEAREBITDA per ShareYoY
-0.03USD-327.24%
0.01USD-92.13%
0.15USD+1.27%
0.15USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cellyan Biotechnology Co Stock analysis

What does Cellyan Biotechnology Co do? Hong Kong Pharma Digital Technology Holdings Ltd is an investment holding company based in Hong Kong that operates within the Air Freight & Logistics industry. The firm is mainly engaged in the over the counter pharmaceutical business and provides two primary services to its clients. The supply chain services offer over the counter pharmaceutical cross-border e-commerce supply chain services. The procurement and distribution services provide over the counter pharmaceutical cross-border procurement and distribution services. Cellyan Biotechnology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cellyan Biotechnology Co stock

EBITDA per Share of Cellyan Biotechnology Co is -0.03 USD in 2026.

EBITDA per Share of Cellyan Biotechnology Co changed from 0.01 USD to -0.03 USD, representing a -327.24% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Cellyan Biotechnology Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Cellyan Biotechnology Co

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Cellyan Biotechnology Co